VKTX position history
The shares of Viking Therapeutics (VKTX) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 447,400 shares, $2.8M, 0.75% of portfolio
- 2021 Q4: 447,400 shares, $2.1M, 0.52% of portfolio
- 2022 Q1: 447,400 shares, $1.3M, 0.35% of portfolio
- 2022 Q2: 462,400 shares, $1.3M, 0.36% of portfolio, Add +3.4%
- 2022 Q3: 552,400 shares, $1.5M, 0.40% of portfolio, Add +19.5%
- 2022 Q4: 521,553 shares, $4.9M, 1.4% of portfolio, Reduce −5.6%
- 2023 Q1: 319,155 shares, $5.3M, 1.6% of portfolio, Reduce −38.8%
- 2023 Q2: 293,655 shares, $4.8M, 1.3% of portfolio, Reduce −8.0%
- 2023 Q3: 319,655 shares, $3.5M, 1.1% of portfolio, Add +8.9%
- 2023 Q4: 248,217 shares, $4.6M, 1.1% of portfolio, Reduce −22.3%
- 2024 Q1: 194,117 shares, $16M, 3.6% of portfolio, Reduce −21.8%
- 2024 Q2: 189,117 shares, $10M, 2.4% of portfolio, Reduce −2.6%
- 2024 Q3: 125,616 shares, $8M, 1.9% of portfolio, Reduce −33.6%
- 2024 Q4: 64,516 shares, $2.6M, 0.66% of portfolio, Reduce −48.6%
- 2025 Q1: 64,516 shares, $1.6M, 0.44% of portfolio
- 2025 Q2: 64,516 shares, $1.7M, 0.47% of portfolio
- 2025 Q3: 64,516 shares, $1.7M, 0.42% of portfolio
- 2025 Q4: 59,516 shares, $2.1M, 0.49% of portfolio, Reduce −7.8%
- 2026 Q1: 59,516 shares, $1.9M, 0.44% of portfolio
- 2026 Q2: 59,516 shares, $2.3M, 0.44% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|